
    
      A single center, randomized, single-dose, open-label, partial-block, four-period, four-way
      crossover study in 54 healthy adult subjects to evaluate the pharmacokinetics and
      bioequivalence of sumatriptan delivered by the Intraject system compared to IMITREX STATdose
      at three injection sites (abdomen, thigh, and arm.)
    
  